Case Challenge

Management of an HBeAg-Negative Patient With Cirrhosis and Elevated Alanine Aminotransferase

Source: Focus on the Virus: A New Paradigm for the Management and Treatment of HBV

Management of an HBeAg-Negative Patient With Cirrhosis and Elevated Alanine Aminotransferase


CME Program Director: Emmet B. Keeffe, MD, MACP

Faculty:

  • Robert G. Gish, MD

CME CREDIT INFORMATION

Release Date: 10/31/06

Expiration Date: 10/30/07


Physicians: maximum of 1.0 AMA PRA Category 1 Credit(s)™

Registered Nurses: 1.4 Nursing CE credits

Status: Please log in to view status


Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe clinical data on current treatment options for chronic hepatitis B
  • Discuss factors in determining candidacy for hepatitis B therapy in HBeAg-negative patients
  • Recount data on the optimal management of hepatitis B patients with decompensated disease

Test your ability to make optimal treatment decisions using patient histories and diagnostic information and see the case unfold according to your choices. Compare your answers with your peers and our expert faculty’s recommendations, and then review the supporting data.
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Educational grant provided by:

Educational grants support only the CME-certified components of this program.